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The Fetal Basis of Adult Disease: Role of the
Environment
It is recognized that between two-percent and
five-percent of all live-born infants have a major
developmental defect. Approximately 40-per-
cent of these defects are thought to be due to
the effect(s) of an adverse exposure of a geneti-
cally pre-disposed fetus to intra-uterine environ-
mental factors. It is now clear that in many cases
the fetus is more sensitive than the adult to the
same environmental insults. Exposure to envi-
ronmental agents during early development can
result in death, structural malformation, and/or
functional alteration of the embryo/fetus. These
toxicant-induced pathogenic responses are most
likely the result of altered gene expression asso-
ciated with altered cell production and cell dif-
ferentiation involved in the establishment of cell
lineages leading to the structural and functional
character of the tissues, organs, and systems that
arise from these lineages.
The National Institute of Environmental
Health Sciences (NIEHS) has a significant pro-
gram that addresses the role of developmental
exposures on structural malformations i.e., classi-
cal birth defects and on functional alterations
whose effects are readily observable early in
development. The purpose of this PA with a set
aside of funds and a Special Emphasis Panel
review by the NIH Center for Scientific Review
is to stimulate research in an important and
emerging area of developmental toxicology: the
effects of in utero exposures that cause perma-
nent functional changes that are not overtly,
grossly teratogenic yet that result in increased
susceptibility to disease/dysfunction later in the
life span. This program announcement seeks to
encourage the application of the new high-
throughput functional-genomic, metabonomic,
proteomic, and bioinformatic technologies to
pursue an understanding of these latent effects of
in utero environmental insult.
The underlying scientific hypothesis behind
the fetal basis of adult diseases has been devel-
oped by epidemiology studies and emphasized by
Dr. David Barker in the United Kingdom. Most
of the supporting studies in this area have con-
centrated on grossly altered nutrition in utero and
its striking influence on multiple aspects of adult
health and disease risk. Dr. Barker has shown
that during development fetuses respond to
severe malnutrition by favoring the metabolic
demands of the growing brain/CNS and heart at
the expense of other tissues. The growing
brain/CNS and heart tissue may not, however,
escape entirely unscathed. The long-term conse-
quences of this response are that the fetus is pro-
tected from death, is live-born, but is more prone
to diseases later in life. In support of the Barker
hypothesis, epidemiology studies have shown
that markers of malnutrition, such as low birth
weight, small for gestation age, frank intra-
uterine growth retardation (IUGR) or clinically
abnormal thinness at birth strongly predicts the
subsequent occurrence of hypertension, hyper-
lipidemia, insulin resistance, type 2 diabetes,
ischemic heart disease, breast cancer or prostate
cancer in adult life. Fetuses that are clinically
malnourished during the first trimester of devel-
opment are three times more likely to be obese as
adults. In addition to malnutrition, environmen-
tal exposures present during in utero development
can have profound influences on fetal growth.
Evidence has been presented in human popula-
tions that gross, heavy exposure to PM10 air pol-
lution containing carcinogenic PAHs can be
correlated with increased IUGR with a peak
impact in the earlier portion of the first
trimester—a most vulnerable period of the cell
lineage expansion, differentiation, and cell inter-
actions events of organogenesis and first growth. 
The concept of fetal programming of struc-
tural-functional formations during development
has been proposed to explain these findings and
the resultant research area is referred to as “Fetal
Basis of Adult Disease” (FeBAD) research.
“Programming” is the term used to describe life-
long changes in function that follow a particular
event in an earlier period of the life span. While
epidemiology studies have identified the phe-
nomenon of metabolic programming, little is
known about the mechanism(s) by which fetal
insults lead to altered programming and to dis-
ease later in life. In addition, emphasis thus far
has been on alterations in nutrition during
development with virtually no focus on the role
that exposures to environmental agents, such as
air or water pollution, either alone or in combi-
nation with qualitative alterations in macro- or
micro-nutrition (i.e. soy protein, phytoestrogens,
isoflavones or other chemicals in herbal supple-
ments or dietary sources), might have on this
phenomenon.
There is, however, evidence that some envi-
ronmental agents, especially those with endocrine
agonist or antagonist activity, may alter develop-
mental programming via alteration in gene
expression or gene imprinting that do not result
in malformations but in functional deficits that
do not become apparent until later in life. In the
reproductive tract, the classic example of this
phenomenon in the environmental area is the
diethylstilbestrol (DES) story. In humans, in
utero exposure to DES leads to an increase in
vaginal adenocarcinoma around the time of
puberty. In mice, neonatal DES exposure leads to
an increase in uterine adenocarcinoma in adult-
hood. While the direct connection has not been
made between in utero programming changes
due to DES and later life disease, it is known that
DES (in the animal studies) results in altered
gene expression in the uterus that is irreversible
without any noticeable gross alterations in uter-
ine morphology. Other examples in the repro-
ductive area include developmental exposures of
the monkey to androgens that lead to polycystic
ovary syndrome-like effects in the adult, data
(still considered controversial) showing that envi-
ronmental estrogens, such as DES, methoxychlor
and bisphenol A, cause alterations in gene expres-
sion in the rat prostate that are irreversible and
are correlated with increased prostate cancer, and
data showing a link between in utero exposure to
dioxin and endometriosis later in life in primates
and rodents.
Cardiopulmonary diseases in postnatal life
have also been linked to prenatal exposure. The
most well-known example is the association
between low birth weight (which is associated
with poor maternal nutrition and perhaps corti-
costeroid exposure) and cardiovascular disease
(e.g., myocardial infarcts) and predictors of
future cardiovascular disease, such as hyperten-
sion and atherosclerosis, and complex metabolic
disease, such as diabetes. In addition, studies
have shown that maternal smoking is associated
with deficits in lung function and with asthma
symptoms in the offspring. Data indicate that
these associations are independent of smoking
status after birth.
Some forms of neurodegenerative disease
may have their origins in in utero exposures. For
example, there is preliminary evidence that a bac-
terial stimulus (endotoxin) can produce cytokines
that impair the development of the mesencephal-
ic dopaminergic systems during pregnancy. This
attenuation of the dopamine neurons during fetal
development leaves the offspring with fewer
dopaminergic neurons at birth and at possible
increased risk for Parkinson's disease in later life.
In a similar vein, there is preliminary evidence
that exposure to environmental neurotoxins dur-
ing dopaminergic development enhances the sus-
ceptibility to accelerated dopaminergic cell death
during aging via the common molecular mecha-
nism(s) of the alteration of stress-activated signal
transduction pathways, expression of differentia-
tion transcription factors, survival factors or
phenotype marker proteins in the nigral
dopaminergic neurons. Similarly there is evi-
dence that in utero exposure to polycyclic biphe-
nols (PCBs) leads to altered thyroid function and
subsequent learning disabilities later in life. In all
instances data are needed to show that the in
utero exposures actually lead to an altered pro-
gramming at the molecular level and that the
disease/dysfunction is a direct result, albeit, tem-
porally discordant in its onset and/or progression,
of that altered programming.
Another promising area for investigation is
how environmental prenatal exposures might alter
immune system programming. The development
of the immune system, including the develop-
ment of the repertoire of reactive lymphocytes
that will exist in postnatal life, begins prenatally.
Alterations of the fetal immune environment
might pre-program the highly sensitive fetal
immune system for aberrant immune regulation,
leading to a loss of tolerance to self-antigens and
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resulting in an increased risk for autoimmune dis-
ease. These changes might manifest in adult life
and perhaps only after a second exposure to relat-
ed environmental chemicals. There is evidence,
for instance, that mice exposed prenatally to estro-
genic compounds appear to develop normal
immune systems. However, when stimulated with
certain environmental chemicals, they can show
an increased susceptibility to autoimmune disease.
Similarly, there is evidence in humans and experi-
mental animals that prenatal exposure to
immunosuppressive drugs can lead to immune
alterations in the mature animals, including devel-
opment of autoantibodies and a higher risk of
autoimmune disease in susceptible animals.
Based on the epidemiology data that support
the Barker Hypothesis and the preliminary data
showing alterations in gene expression and
imprinting due to in utero exposures to some
environmental agents, we propose that exposure
to certain environmental chemicals as well as
altered nutrition, or in combination with altered
nutrition, will in some situations, not lead to
easily identifiable structural malformations, but
instead to alterations in developmental program-
ming expressed as a permanently altered gland,
organ or system potential. These states of altered
potential would be a result of changes in gene
expression, due to altered imprinting, and the
underlining methylation-related protein-DNA
relationships associated with chromatin remodel-
ing. These effects may occur in a time specific
(i.e. vulnerable window) and tissue specific man-
ner and such alterations may be irreversible. The
end-result is an animal that is sensitized such
that it will be more susceptible to diseases later
in life. The environmental insult could act via a
one hit or two/three hit scenario. That is, there
could be an in utero exposure that would lead by
itself to pathophysiology later in life or there
could be in utero exposure combined with a
neonatal exposure (same or different com-
pound(s) or adult exposure that would trigger
the pathophysiology. The pathophysiology or
functional change that results from the expo-
sures/insult could lead to: a) the occurrence of a
disease that otherwise would not have happened,
b) an increase in risk for a disease that would
normally be of lower prevalence, or c) either an
earlier onset of a disease that would normally
have occurred or an exacerbation of the disease.
Finally, the pathophysiology could have a vari-
able latent period from onset in the neonatal
period, to early childhood, to pubertal, to early
adulthood to late adulthood depending on the
toxicant, time of exposure and tissue/organ
affected and potentially transgenerational effects.
Research Approaches Relevant to this PA: 1)
To provide a sound mechanistic understanding of
fetal programming of adult disease, studies sup-
ported by this initiative must involve whole ani-
mal developmental exposures during gestation.
Applicants can propose studies using transgenics,
model organisms, or rodent models. For the pur-
pose of this initiative, human studies (clinical or
epidemiology) are not responsive; 2) Applicants
must study an environmental agent/chemical/
stressor to which there is human exposure and the
potential for in utero exposure. This includes any
endocrine active chemical(s) or organic solvents,
particulate matter (PMs), pesticides, nutritional
supplements, phytochemicals or metals. Nutrition
alone cannot be used as an in utero exposure but
can be studied in conjunction with another expo-
sure; 3) Applications must propose studies that
focus on in utero exposures, but additional expo-
sures at other time points (e.g., exposure begin-
ning in utero and extending to postnatal period;
exposure in utero followed by adult exposure) can
be included; 4) This initiative requires the use of
the new technologies of gene expression profiling,
and where appropriate, the examination of epige-
netics (methylation, imprinting and chromatin
remodeling); 5) Applications must link in utero
exposures to changes in gene expression that are
tissue specific and irreversible. These changes in
gene expression will then need to be measured in
the adult and correlated with the diseases/dys-
function studied; 6) A specific adult onset disease
or dysfunction must be the focus of the applica-
tion with emphasis on the role of in utero expo-
sure and changes in gene expression in the fetus to
the adult onset or severity of the disease.
Applications that are not focused on a specific
adult disease or dysfunction are not responsive.
For example, applications that focus on in utero
exposures as triggers of diseases of childhood or
puberty are not responsive to this specific P; 7)
Applications must focus on one of the following
four emphasis areas: the reproductive tract, the
pulmonocardiovascular system, the brain/nervous
system or the immune/autoimmune system.
Diseases of tissues or organ systems other than the
four described here are not responsive to this spe-
cific announcement. The diseases of special inter-
est to NIEHS with respect to this initiative
include reproductive/hormonal (fertility,
endometriosis, fibroids, premature menopause,
polycystic ovary syndrome, prostate/ovary/breast
cancer) cardiopulmonary (heart disease, athero-
sclerosis, hypertension, chronic obstructive pul-
monary disease, adult asthma) and brain/CNS
(neurodegenerative diseases—Parkinson's,
Alzheimer) and immune/autoimmune (altered
immune responsiveness, systemic or tissue specific
autoimmine diseases of adulthood). It may be
possible to submit applications to this initiative
with an emphasis on other diseases as long as they
are related to one or more of the above noted four
emphasis areas. It should be noted that these are
all adult onset diseases; 8) Critical areas of
expertise that are required of applicants include
developmental biology/toxicology, disease patho-
physiology and gene expression profiling, includ-
ing data analysis and interpretation of global gene
expression alterations; 9) The National Cancer
Institute (NCI) is interested in funding research
aimed at understanding the effects of biological,
chemical, and radiologic exposures in utero that
cause permanent functional changes that result in
increased susceptibility to cancer in adult life. The
specific etiologic agents of interest include
microorganisms such as herpes virus,
HHV8/KSHV, cytomegalo virus, papilloma
virus, polyoma virus, and bacterial infection such
as chlamydia, to name a few. Chemical agents
that have been characterized as carcinogenic, or
are suspected to be carcinogenic in humans
including polycyclic aromatic hydrocarbons,
nitrosamines, heterocyclic amines, aromatic
amines, DES and estrogens, as well as metals and
metalloids such as chromium, mercury and
arsenic are of interest to NCI. Additionally, expo-
sures to radiologic agents from all externally
applied sources as well as exposure to internally
deposited radionuclides that would result in in
utero exposures are of interest in this context.
Studies which link in utero exposures to such
agents that result in permanent, alterations in
gene expression in tissues of the reproductive sys-
tem, the pulmono/cardiovascular system, the
brain/nervous system, or the immune/autoim-
mune system leading to or resulting in cancer in
those organ sites later in the adult life of the
exposed fetus are sought by the NCI; 10) The
NCI is also interested in funding research aimed
at understanding the consequences of fetal expo-
sure to toxicants, hormone agonists, or antago-
nists that alter the expression or function of the
steroid nuclear receptor superfamily of genes
(androgen, estrogen, progesterone, glucocorticoid,
Vitamin D3, thyroxine) in normal or cancerous
organs of the male and female reproductive tract
and/or immune system. In addition, the conse-
quences of environmental carcinogen or tobacco
smoke exposure of mice during gestation that
result in long lasting immune function deficien-
cies or inflammatory responses, in so far as they
are related to the development of hematological
malignancies, or cancers of the reproductive sys-
tem, the brain/nervous system and/or the lung.
Studies which link fetal exposure to toxicants or
other substances affecting somatic stem cells that
later populate organs such as the mammary gland,
the prostate gland and the lung, and that have
cancer as the endpoint, are sought by the NCI. 
This PA will use the NIH exploratory/devel-
opmental (R21) award mechanism. As an appli-
cant, you will be solely responsible for planning,
directing and executing the proposed project.
The R21 grant award mechanism supports inno-
vative, high-risk/high-impact research requiring
preliminary testing or development; exploration
of the use of approaches and concepts new to a
particular substantive area; and research and
development of data upon which significant
future research may be built. Applications will be
considered high-impact if they demonstrate the
potential for groundbreaking, precedent setting
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significance, and high-risk because they either
lack sufficient preliminary data to ensure their
feasibility, or involve the use of a new model sys-
tem or technique.
This PA uses just-in-time concepts. It also
uses the modular budgeting format (see http://
grants.nih.gov/grants/funding/modular/modu-
lar.htm). Specifically, if you are submitting an
application with direct costs in each year of
$250,000 or less, use the modular format. This
program does not require cost sharing as defined
in the current NIH Grants Policy Statement at
http://grants.nih.gov/grants/policy/nihgps_2001/
part_i_1.htm.
It is anticipated that approximately $2 mil-
lion in FY 2004 and FY 2005 will be available to
fund grants in response to this PA. An applicant
for an R21 grant may request a project period of
up to three years and a budget for total direct
costs, including third party facilities and adminis-
trative costs, not to exceed $100,000 per year.
Because the nature and scope of the proposed
research will vary from application to application,
it is anticipated that the size and duration of each
award will also vary. Although the financial plans
of the NIEHS provide support for this program,
awards pursuant to this PA are contingent upon
the availability of funds and the receipt of a suffi-
cient number of meritorious applications.
Prospective applicants are asked to submit a
letter of intent that includes the following infor-
mation: 1) Descriptive title of the proposed
research; 2) Name, address, and telephone num-
ber of the Principal Investigator; 3) Names of
other key personnel; 4) Participating institu-
tions; 5) Number and title of this PA.
Although a letter of intent is not required, is
not binding, and does not enter into the review
of a subsequent application, the information that
it contains allows NIEHS staff to estimate the
potential review workload and plan the review.
The letter of intent is to be sent by the date
listed at the beginning of this document. It
should be sent to:
Dr. Cindy Lawler, Scientific Program
Administrator, Cellular, Organ and Systems
Pathobiology Branch, Division of Extramural
Research and Training, NIEHS, P.O. Box 12233
(EC-23), 111 T.W. Alexander Drive, Research
Triangle Park, NC 27709, 919 316-4671, fax:
919-541-5064, e-mail: lawler@niehs.nih.gov.
Applications must be prepared using the PHS
398 research grant application instructions and
forms (rev. 5/2001). The PHS 398 is available at
http://grants.nih.gov/grants/funding/phs398/
phs398.html in an interactive format. For further
assistance contact GrantsInfo, 301-435-0714, e-
mail: GrantsInfo@nih.gov. Applicants should
note that R21 applications have a page limitation
of 15 pages for the Research Plan.
Application Receipt Dates: Applications sub-
mitted in response to this PA will be accepted on
August 12, 2003 and 2004.
Contact: Dr. Cindy Lawler, Scientific
Program Administrator, Cellular, Organ and
Systems Pathobiology Branch, Division of
Extramural Research and Training, NIEHS,
P.O. Box 12233 (EC-23), Research Triangle
Park, NC 27709, USA, 919-316-4671, fax: 919-
541-5064, e-mail: lawler@niehs.nih.gov; Jerry
Heindel, Scientific Program Administrator,
Cellular, Organ and Systems Pathobiology
Branch, Division of Extramural Research and
Training, NIEHS, P.O. Box 12233 (EC-23),
Research Triangle Park, NC 27709, USA, 919-
541-0781, fax: 919-541-5064, e-mail: hein-
delj@niehs.nih.gov; J. Patrick Mastin, Scientific
Program AdministratorCellular, Organ and
Systems Pathobiology BranchDivision of
Extramural Research and Training, NIEHS,
P.O. Box 12233 (EC-23), Research Triangle
Park, NC 27709, USA, 919-541-3289, fax: 919-
541-5064, e-mail: mastin@niehs.nih.gov;
Annette Kirshner, Scientific Program
Administrator, Cellular, Organ and Systems
Pathobiology Branch Division of Extramural
Research and Training, NIEHS, P.O. Box 12233
(EC-23), Research Triangle Park, NC 27709,
USA, 919 541-0488, fax: 919-541-5064, e-mail:
kirshner@niehs.nih.gov; Carol L. MacLeod,
Cancer Biology Division, National Cancer
Institute, 6130 Executive Boulevard, Rockville,
MD 20892, USA, 301 435 1878, fax: 301 480
0864, e-mail: macleodc@mail.nih.gov; Mary
Frances Picciano, Senior Nutrition Research
Scientist, Office of Dietary Supplements,
National Institutes of Health, 6100 Executive
Boulevard, MSC 7517 Suite 3B01, Bethesda,
MD 20892-7517 (Courier Service use Rockville,
MD 20852), 301-435-3608, fax: 301-480-1845.
Reference: PA No. PAR-03-121
Genetics, Behavior, and Aging 
This program announcement (PA) solicits novel
research integrating genetics, behavior and aging.
Human and non-human studies are needed to
advance our understanding of the genetic and
environmental influences and processes affecting
variability in behavior and its functional sequelae
with age. This includes studies that help elucidate
the relationships of levels and change in behavior
to health, functional competence, and quality of
life of older adults. This PA is framed around two
broad categories of questions: (1) gene-to-behav-
ior questions concerning the nature and role of
genetic influences on behaviors at older ages, and
how these genetic effects vary with age; and (2)
questions about dynamic processes including
gene-environment interactions, gene-environ-
ment covariation, age-related genetic effects, and
how behaviors interact with and affect genetic
expression. The behaviors that are eligible for
study under this PA should be critical to quality
of life among the aged, either as outcomes or as
mediators of physical or cognitive health and
function. Examples of relevant behavioral
domains include, but are not limited to, social
behaviors, resilience, vitality, adaptivity, personal-
ity, vulnerability to stress, health behaviors, social
cognition, human and social capital accumula-
tion, economic savings for retirement, risk-tak-
ing, happiness, coping, caregiving, cognitive
abilities, cognitive flexibility, cognitive reserve,
learning, and functional abilities. This PA is
intended to stimulate methodologically rigorous
research integrating genetics, other biological sci-
ences, and the behavioral and social sciences. To
be considered responsive to this announcement,
interdisciplinary perspectives must be unambigu-
ous, the relationship between the behaviors or
social processes under study and healthy aging
should be articulated, and the proposed study
should be embedded within a well articulated set
of questions or hypotheses generated from social
science and behavioral research. This announce-
ment updates and replaces a previous PA,
Behavior Genetics in Adulthood and Old Age
(PAS-98-076, issued May 21, 1998).
Behavior and age-related changes in behav-
ioral processes are integral to how well we age.
Many behavioral phenotypes, such as resilience,
cognitive and functional abilities, social connect-
edness, happiness, longevity and loneliness are
intrinsic to maintaining health and quality of
life. Behavior also plays a critical mediating role
(e.g. smoking, alcohol use, exercise, risk taking
behaviors, adherence, social engagement) in
health and disease. Understanding the causes of
variation in behavioral development, plasticity,
stability, adaptation and change with age is
essential to maintaining and enhancing quality
of life throughout old age. 
Family and twin studies on aging have
demonstrated the importance of genetic influ-
ences for variation in a large array of behavioral
phenotypes related to personality, well-being,
functional abilities, cognitive aging, longevity
and health. More recent findings based on the
longitudinal twin design indicate the importance
of genetic influences on functional stability and
the importance of environments for change. To
move beyond these findings innovative studies
are needed that investigate genetic effects within
the context of the dynamic aging processes in
which they are expressed. This will involve
diverse approaches that: integrate molecular and
quantitative methods, focus on behavioral sys-
tems for which known or candidate genes are
identified, explore social processes that affect
individual environments, include measures of
biological intermediaries of the behaviors, and
use non-linear analytic approaches to study
genes, social factors and environments in devel-
opmentally dynamic ways.
The underlying conceptual model is multi-
factorial, highlighting the combined action of
multiple genetic and environmental influences
where phenotypic variation arises as a function
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of genotypic and environmental differences
between people within a particular population.
Features of this model are an assumption that
environmental influences, ranging from intracel-
lular conditions to larger socio/cultural effects,
and genetic influences operate through the same
causal field of biological structures and processes.
The intricacies of this causal field can lead to
complex relationships between genetic factors,
environmental influences, and phenotypic out-
comes. These complexities include time-related
changes in the relative influence of genetic and
environmental factors, non-linear interactions
among genes, interactions and correlations
between genes and environments and environ-
mentally induced gene expression.
The need to examine genetic and environ-
mental influences and behaviors in the context
of dynamism of interactive aging systems is
increasingly apparent, and unprecedented
opportunities to do so are now available.
Dramatic advances have been made by molecu-
lar geneticists in the explication of hereditary
phenomena, by quantitative geneticists in the
assessment of aggregate effects of genes and envi-
ronments, by behavioral and social scientists in
identifying intermediary phenotypes (endophe-
notypes) and in defining and measuring complex
behavioral domains, and by statisticians in the
measurement of change. Progress in understand-
ing gene-behavior relationships in aging will rely
on integrating the theoretical models and
methodologies of these research domains to pro-
vide powerful tools for combining reductionist
approaches (that explore the nature of specific
genetic and environmental influences) and inte-
grationist approaches (that explore effects within
the larger context of complex systems). Among
many examples, improved strategies now exist to
identify genes and map quantitative trait loci
(QTL); to assess specific genetic and environ-
mental sources of variation; to quantify these
specific effects relative to background variation
due to the aggregate influence of still-anony-
mous genes and environments; to conceptualize
and examine non-linear and dynamic processes
such as epistasis, gene-environment interaction,
gene-environment correlation, and behaviorally
or environmentally induced genetic expression;
to investigate how social worlds and behavioral
factors modulate gene expression; to characterize
population differences according to sequence
(SNP) and haplotype diversity; to detail the
structure of behavioral domains; to measure phe-
notypic change; and to assess age-related changes
in influence of both specific and aggregate genet-
ic and environmental domains.
A wide range of designs is relevant to the
objectives of this PA, including augmented family
studies with combinations of twins, parents, sib-
lings, children and adoptees; sibling studies using
highly selected samples for phenotypic indices of
similarity/dissimilarity; extended pedigrees; special
populations (i.e. inbred groups, cultural and
genetic isolates); sub-populations such as the old-
est-old; studies that utilize the extensive genome
databases and genetic analyses resources that are
becoming available; and animal model studies
using cross-fostering, selective breeding, inbred
strains, recombinant inbred strains or specific
genotypic manipulations (e.g. transgenic, knock-
outs, knock-ins). Research is also encouraged that
builds upon ongoing studies of aging cohorts
whereby supplemental data collection would
allow new hypotheses to be addressed at the inter-
section of genetics, behavioral and social science
and research.
Major methodological considerations should
be well articulated, including the implications
for aging of the behavioral phenotypes being
studied, documentation of solid measurement
characteristics, presentation of power analyses to
reveal that sample sizes suffice for analyzing the
genetic effects being studied, and clear descrip-
tions of the analytical procedures to be employed
must be provided. The research team should be
multidisciplinary and, at a minimum, reflect
expertise in genetics (molecular and/or quantita-
tive), and the social/behavioral sciences. 
Among the many research avenues pertinent
to studying the behaviors of relevance to this PA
are 1) Studies that explore the genetics of behav-
ioral interventions and address how genetic dif-
ferences moderate responses among the elderly to
health promoting behaviors (e.g. exercise, social
connectedness, cognitive training); 2) Studies to
elucidate behavior-gene (i.e. individuate loci and
QTLs) relationships for behaviors affecting quali-
ty of life with aging. Novel, hypothesis-driven
research is needed to: a) investigate how genes or
QTLs implicated in aging processes (e.g. oxida-
tive stress) affect behavioral function and change,
and b) explore age effects in the genes or QTLs
implicated in behavioral functioning (e.g. DRD4
and novelty-seeking, APOE and cognitive func-
tion); 3) Behavioral genetic designs (using human
or animal models) that combine quantitative and
molecular techniques to resolve variance and
covariance structures more finely than has previ-
ously been accomplished by quantifying the
influences of specific genes, QTLs and specific
measured environments; 4) Behavioral genetic
studies (using human or animal models) that
investigate genetic variation and QTLs affecting
rates and shapes of change in behavioral func-
tioning; 5) Studies of specific environmental
influences in genetically informative research on
aging. Despite the importance of dynamic
processes involving gene-environment interaction
and covariation, measured environments are
rarely included in human studies. Research is
needed that incorporates critical features of
diverse environments (i.e. social, economic, phys-
ical and cultural environments) into behavioral
genetic studies of aging for the purpose of analyz-
ing gene-environment dynamics; 6) Studies
(using human or animal models) to investigate
gene by environment interaction. Examples
include research exploring whether and how
social environments or enriched experiences
(quality of education, etc.) mediate progression
to disease among those with genetic predisposi-
tions to disease; studies investigating the effects of
socially or experientially enriched or restricted
environments on genetic expression; research
testing whether protective health effects conferred
by education prevail in the presence of genetic
risk, and genetic research that builds upon and
bridges findings from established fields of envi-
ronmental inquiry (e.g. health disparities) to
explore gene by environment interactions; 7)
Studies elucidating the genetic regulation of
neural mechanisms, and their modulation by
environmental circumstances, that impact upon
cognitive function, cognitive reserve and flexibili-
ty, learning, and memory; 8) Studies to investi-
gate gene by environmental covariation.
Individuals shape and select their environments
throughout development, and these processes are
affected by many factors including age, and aging
transitions such as retirement, chronic care giv-
ing, bereavement, isolation and functional loss.
Research is needed that develops analytical mod-
els by which to study gene-environment covaria-
tion in the context of these age-related changes in
abilities to define and select one's environment. 
This PA will use the NIH R01 award mech-
anism. As an applicant, you will be solely
responsible for planning, directing, and execut-
ing the proposed project. 
This PA uses just-in-time concepts. It also
uses the modular as well as the non-modular
budgeting formats (see http://grants.nih.gov/
grants/funding/modular/modular.htm).
Specifically, if you are submitting an application
with direct costs in each year of $250,000 or
less, use the modular format. Otherwise follow
the instructions for non-modular research grant
applications.
The National Institute on Aging (NIA)
intends to commit at least $2 million for an ini-
tial round of funding of applications of high sci-
entific merit in FY 2004. An applicant may
request a project period of up to 5 years. Because
the nature and scope of the proposed research
will vary from application to application, it is
anticipated that the size and duration of each
award will also vary. Although the financial
plans of the NIA provides support for this pro-
gram, awards pursuant to this PA are contingent
upon the availability of funds and the receipt of
a sufficient number of meritorious applications. 
An overarching goal of this PA is to encour-
age innovative research integrating knowledge
and methodologies from genetics, gerontology,
and the behavioral and social sciences.
Applications should articulate the interdiscipli-
nary dimensions and components of the pro-
posed research, and explain how the collectiveA 604 VOLUME 111 | NUMBER 11 | August 2003 • Environmental Health Perspectives
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expertise of the research team meets these inter-
disciplinary requirements with regards to the
specific aims to be investigated. 
The sharing of unique resources such as phe-
notypic data, DNA, and genome scans in a time-
ly manner contributes greatly to progress in
understanding the genetics of complex pheno-
types. The NIH encourages data sharing (http://
grants.nih.gov/grants/guide/notice-files/NOT-
OD-03-032.html) and requires all applications
from October 1, 2003 that request $500,000 or
more in direct costs in any single year to address
data sharing. For this PA, investigators are
encouraged to submit a data-sharing plan
regardless of the size of the requested budget.
The NIH data sharing and implementation
guidelines policies can be found at http://
grants.nih.gov/grants/policy/data_sharing/
data_sharing_guidance.htm. NIH staff will eval-
uate the adequacy of the proposed data sharing
and access plan, and consider it in making award
decisions. Staff will also consider waivers as
appropriate to the conditions of data collection.
Also, except under circumstances where the data
are likely to be of unique value and importance
to other investigators, staff will accept requested
costs under $500,000 a year as sufficient reason
for a waiver. The sharing plan approved by NIH
staff, after negotiation with the applicant when
necessary, will become part of the terms and
conditions of the award. NIH staff will also eval-
uate compliance with the sharing plan and scien-
tific progress in the non-competing continuation
of the grant award application.
Applications must be prepared using the
PHS 398 research grant application instructions
and forms (rev. 5/2001). The PHS 398 is avail-
able at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format.
For further assistance contact GrantsInfo, 301-
435-0714, e-mail: GrantsInfo@nih.gov.
Applications submitted in response to this
PA will be accepted at the standard application
deadlines, which are available at http://
grants.nih.gov/grants/dates.htm. Application
deadlines are also indicated in the PHS 398
application kit. Submit a signed, typewritten
original of the application, including the check-
list, and five signed photocopies in one package
to: Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1040, MSC 7710, Bethesda, MD 20892-
7710, USA, Bethesda, MD 20817 (for express/
courier service)
Applications must be received by or mailed
on or before the receipt dates described at
http://grants.nih.gov/grants/funding/submis-
sionschedule.htm. The CSR will not accept any
application in response to this PA that is essen-
tially the same as one currently pending initial
review unless the applicant withdraws the pend-
ing application. The CSR will not accept any
application that is essentially the same as one
already reviewed. This does not preclude the
submission of a substantial revision of an appli-
cation already reviewed, but such application
must include an Introduction addressing the
previous critique.
Contact: Angie Chon-Lee, Behavioral and
Social Research Program, NIA, Gateway
Building, Room 533, Bethesda, MD 20892-
9205, USA, 301-594 5943, fax: 301-402-0051,
e-mail: Chon-LeA@nia.nih.gov; Marilyn M.
Miller, Neuroscience and Neuropsychology of
Aging Program, National Institute on Aging,
Gateway Building, Suite 350, 7201 Wisconsin
Avenue, Bethesda, MD 20892-9205, USA,
301-496-9350, fax: 301-496-1494, e-mail:
Millerm@nia.nih.gov. Reference: PA No.
PAS-03-128
Gene-Environment Interactions Influencing
Alcohol-Related Phenotypes and Diseases
The National Institute on Alcohol Abuse and
Alcoholism (NIAAA) is seeking research grant
applications on the role of gene-environment
interactions underlying susceptibility to alcohol-
related phenotypes including alcohol depen-
dence, relapse, withdrawal; alcohol-induced
organ damage including neurodegeneration, cir-
rhosis and other liver diseases, pancreatitis, car-
diomyopathy, immune disorders, cancers, and
alcohol-induced birth defects. This solicitation
specifically encourages multidisciplinary
approaches to study how environmental condi-
tions, such as chemical, infectious, physical,
nutritional, and social behavioral factors, impact
genetic predisposition to alcohol-related diseases.
Identification and characterization of gene-envi-
ronment interactions will offer better opportuni-
ties to effectively target prevention, intervention
and treatment strategies. The National Institute
of Environmental Health Sciences (NIEHS) is
collaborating on this PA and is seeking research
grant applications on interactions between alco-
hol effects and environmental agents.
Alcoholism and alcohol-related diseases are
the result of complex interactions of multiple
genetic and environmental factors. Several genet-
ic factors have been associated with alcohol-relat-
ed behaviors, alcohol-induced birth defects, and
alcohol-induced organ damage; however, the
role of environmental factors in modifying the
risk of developing alcohol abuse, alcoholism,
and/or organ damage remains undefined. 
Genetic factors leading to differential risk
for alcoholism were demonstrated using twin
and family studies. In addition, functional poly-
morphisms of alcohol dehydrogenase (ADH2)
and aldehyde dehydrogenase (ALDH2) genes
have been shown to have a significant impact on
alcohol metabolism in the liver, and thus, may
contribute to vulnerability to alcohol abuse and
dependence, alcohol-related liver diseases and
cancers.
Genetic and environmental interactions
modulate an individual's susceptibility to certain
diseases/disorders. For example, male children
who have a polymorphism in the monoamine
oxidase A gene conferring low enzyme activity
show non aggressive behavior when raised in a
non-abusive environment. However, male chil-
dren with the same polymorphism show aggres-
sive and antisocial behavior when raised in an
abusive environment. Males with normal
enzyme activity do not become violent offenders
when raised in the same abusive/maltreated envi-
ronment. Similar results have been found in ani-
mals. For example, mice lacking a functional
corticotroping-releasing hormone 1 receptor do
not differ from wild-type mice in alcohol intake
under stress-free conditions; however, after
repeated stress, the knockout mice increase their
alcohol consumption. Also, monkeys with a
polymorphism in the regulatory region of the
serotonin transporter gene show no differences
from the wild-type monkeys when reared with
their mothers. However, monkeys with the poly-
morphism that were nursery raised have atten-
tion and orientation deficits. 
The dynamic multi-level interactions
between genetic and environmental components
are responsible for the heterogeneity and com-
plexity of alcohol dependence phenotypes.
Therefore, it is necessary to use multi-disciplinary
approaches to decipher the underlying mecha-
nisms for alcohol abuse, alcohol dependence and
alcohol related disorders. Comprehensive designs
and methodologies for both human and animal
studies of gene-environment interactions are of
crucial importance to identify alcohol-related
genes and environmental factors, and their inter-
relationships. Human studies using informative
populations such as twins, multi-generation fami-
lies and migrants, as well as children at high risk
or low risk to develop alcohol dependence can
provide unique opportunities and advantages to
study neurobiological and behavioral conse-
quences of gene-environment interaction. In
addition, animal models can be used to study
gene-environment interactions requiring genetic
and environmental manipulations that are
impractical or ethically impossible in humans.
Controlled genotypes can be devised in genetical-
ly modified or chemical-induced mutant animals.
Therefore, animal models can also offer unique
opportunities to explore the role of gene-environ-
ment interactions as the means of understanding
the pathways to alcohol-induced diseases. 
There are several approaches for analyzing
the effects of environmental factors in experi-
mental animals, including differential gene
expression using cDNA microarrays, RAGE, and
SAGE; as well as proteomic methods to deter-
mine changes in protein levels and protein mod-
ifications. The role of genes implicated in the
response may be further studied by developing
transgenic and gene-targeted animals, as well as,Environmental Health Perspectives • VOLUME 111 | NUMBER 11 | August 2003 A 605
by using other gene expression strategies includ-
ing RNA interference (RNAi) and retroviral-
mediated gene transfer techniques.
Epigenetic changes are known to be
involved in the etiology of a large number of dis-
eases such as schizophrenia, cancer, and alcohol
dependence. Recent evidence shows that there is
an association between the GABAA receptors
and alcohol dependence that is modulated by
genetic imprinting. There are numerous types of
epigenetic modifications on both DNA and
nucleosomes, including methylation and acetyla-
tion, which could affect the expression and regu-
lation of alcohol-related genes. NIAAA seeks
proposals that will examine environmental fac-
tors that alter the epigenetic status of genes that
may affect gene expression leading to alcohol-
induced diseases.
The purpose of this PA is to encourage
multidisciplinary research that will investigate
gene-environment interactions influencing sus-
ceptibility to alcohol abuse and dependence,
alcohol-related behaviors, and alcohol-induced
organ damage in both animals and humans.
NIAAA seeks research projects that include, but
are not limited to: 
1) studies of changes in gene or protein
expression by investigating animal models such as
knock-out and other genetically modified animals
under a variety of environmental conditions to
identify candidate genes, or their corresponding
proteins, that may be associated with susceptibili-
ty to alcohol abuse and dependence, relapse, with-
drawal, alcohol-induced organ damage including
neurodegeneration, cirrhosis and other liver dis-
eases, pancreatitis, cardiomyopathy, immune dis-
orders, cancers, and alcohol-induced birth defects;
2) studies to identify allelic variants (polymor-
phisms) and determine the functional relevance of
an identified gene or protein for increasing or
decreasing susceptibility to alcohol abuse and
dependence, alcohol-related phenotypes, and
other alcohol-induced diseases under different
environmental conditions; 3) studies using genetic
epidemiological, psychiatric and behavioral genet-
ic and molecular genetic methods to determine
the interaction of genetic, biological, and social
factors in the development of risk to alcohol abuse
and dependence; 4) studies to develop and/or uti-
lize statistical modeling approaches to identify the
contributions of genetic and environmental fac-
tors to the individual risk, their interrelationship
and their developmental trajectories; 5) studies to
determine the genetic and environmental risk and
protective factors that influence individual drink-
ing behaviors including children and adolescent
underage drinking across populations, socio-cul-
tural backgrounds, and environmental exposures;
6) studies to determine the environmental factors
that alter the epigenetic status of genes, thus
increasing vulnerability to alcohol abuse and
dependence, alcohol-associated behaviors, and
alcohol-induced organ damage;
7) studies to determine the functional rele-
vance of candidate genomic markers associated
with an increased susceptibility to alcohol abuse
and dependence, alcohol-related phenotypes, and
alcohol-associated medical conditions; 8) studies
to identify potential links between alcohol expo-
sure and expression of functional polymorphisms
of neurotransmitters and their receptors under
various environmental conditions such as stress
and cross-fostering, to understand the develop-
ment of excessive drinking behaviors; 9) studies
to determine how genetic variations between
individuals and among various populations
impact on how environmental influences may
differentially alter alcohol metabolism.
NIEHS seeks research grant applications in
which the goals are to determine gene-environ-
ment effects on disease susceptibility in response
to specific exposures or which involve
Environmentally Responsive Genes, for exam-
ple, as defined in the Environmental Genome
Project (http://egp.gs.washington.edu/). NIEHS
seeks applications that focus primarily on expo-
sure to environmental agents and in which
attention to alcohol abuse is secondary or minor.
This PA will use the NIH R01 and
Exploratory/Developmental Research Grant
(R21) award mechanisms. As an applicant, you
will be solely responsible for planning, directing,
and executing the proposed project. Applications
using the R21 mechanism may request a project
period of up to two years with a combined bud-
get for direct costs of up $275,000 for the two
year period. For example, the applicant may
request $100,000 in the first year and $175,000
in the second year. The request should be tai-
lored to the needs of the project. Normally, no
more than $200,000 may be requested in any
single year. 
This PA uses just-in-time concepts. It also
uses the modular as well as the non-modular bud-
geting formats (see http://grants.nih.gov/grants/
funding/modular/modular.htm). Specifically, if
you are submitting an application with direct
costs in each year of $250,000 or less, use the
modular format. Otherwise follow the instruc-
tions for non-modular research grant applications.
This program does not require cost sharing as
defined in the current NIH Grants Policy
Statement at http://grants.nih.gov/grants/
policy/nihgps_2001/part_i_1.htm. Exploratory/
developmental grant support is for new projects
only; competing continuation applications will
not be accepted. Two revisions of a previously
reviewed exploratory/developmental grant appli-
cation may be submitted as defined in NIH
Policy at http://grants.nih.gov/grants/policy/
amendedapps.htm.
Applications must be prepared using the PHS
398 research grant application instructions and
forms (rev. 5/2001). The PHS 398 is available at
http://grants.nih.gov/grants/funding/phs398/
phs398.html in an interactive format. For further
assistance contact GrantsInfo, Telephone (301)
435-0714, Email: GrantsInfo@nih.gov.
Application Receipt Dates: Applications
submitted in response to this PA will be accept-
ed at the standard application deadlines, which
are available at http://grants.nih.gov/grants/
dates.htm. Application deadlines are also indi-
cated in the PHS 398 application kit.
Application Processing: Applications must
be mailed on or before the receipt dates
described at http://grants.nih.gov/grants/fund-
ing/submissionschedule.htm. The CSR will not
accept any application in response to this PA
that is essentially the same as one currently
pending initial review unless the applicant with-
draws the pending application. The CSR will
not accept any application that is essentially the
same as one already reviewed. This does not pre-
clude the submission of a substantial revision of
an application already reviewed, but such appli-
cation must include an Introduction addressing
the previous critique. 
Contact: Zhaoxia Ren, Program Director,
Genetics and Proteomics Research Branch,
Division of Basic Research, NIAAA, 6000
Executive Boulevard, Suite 402, MSC 7003,
Bethesda, MD 20892-7003 USA, 301-443-5733,
fax: 301-594-0673, e-mail: zren@mail.nih.gov;
Lisa A. Neuhold, Program Director, Genetics and
Proteomics Research Branch, Division of Basic
Research, NIAAA, 6000 Executive Boulevard,
Suite 402, MSC 7003, Bethesda, MD 20892-7003
USA, 301-594-6228, fax: 301-594-0673, e-mail:
Lneuhold@willco.niaaa.nih.gov; Ellen Witt,
Program Director, Neuroscience and Behavior
Research Branch, Division of Basic Research,
NIAAA, Willco Bldg, Suite 402, 6000 Executive
Blvd, MSC 7003, Bethesda, MD 20892-7003
USA, 301- 443-6545, fax: 301-594-0673, e-mail:
ewitt@willco.niaaa.nih.gov; Vivian B. Faden,
Chief, Epidemiology Branch, Division of Biometry
and Epidemiology, NIAAA, 6000 Executive
Boulevard, Suite 402, MSC 7003, Bethesda, MD
20892-7003 USA, 301-592-6232, fax: 301-443-
8614, e-mail: vfaden@mail.nih.gov; Leslie Reinlib,
Scientific Program Administrator, Susceptibility
and Population Health Branch, Division of
Extramural Research and Training, NIEHS, PO
Box 12233, MD-EC-21, Research Triangle Park,
NC 27711-0001 USA, 919-541-4998, fax: 919-
316-4606, e-mail: reinlib@niehs.nih.gov.
Reference: PA No. PA-03-141
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